Evidence map›Paper›PMID 41486460›Full record

ArticleJournal of pediatric gastroenterology and nutrition2026

Oral rotavirus vaccine effectiveness among malnourished children in 19 countries: Findings from the MNSSTER-V project.

Eleanor Burnett, Ismail Ticklay, Jazmina Umana, Inacio Mandomando, Annick Lalaina Robinson, Richard Omore, David M Goldfarb, Najibullah Safi, Nguyen Van Trang, Annet Kisakye and 16 more

Abstract read
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Eleanor BurnettViral Gastroenteritis Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-7541-6156
Ismail TicklayChild and Adolescent Health Unit, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe.
Jazmina UmanaExpanded Program Immunization, Ministerio de Salude, Managua, Nicaragua.
Inacio MandomandoInstituto Nacional de Saúde (INS), Marracuene, Maputo, Mozambique.
Annick Lalaina RobinsonCHU Mère Enfant Tsaralalàna, Antananarivo, Madagascar.
Richard OmoreKenya Medical Research Institute (KEMRI), Centre for Global Health Research (CGHR), Kisumu, Kenya.
David M GoldfarbUniversity of British Columbia, Vancouver, Canada.
Najibullah SafiJS Consultancy, Kabul, Afghanistan.
Nguyen Van TrangNational Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
Annet KisakyeUganda Country Office, World Health Organization, Kampala, Uganda.
Jeannine UwimanaDepartment of Pathology, Kigali University Teaching Hospital, Institute of Applied Sciences, Kigali, Rwanda.
Kofi N'ZueCote d'Ivoire Country Office, World Health Organization, Abidjan, Cote d'Ivoire.
Michelle J GroomeSouth African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Christabel Enweronu-LaryeaUniversity of Ghana Medical School, Accra, Ghana.
Isidore BonkoungouUniversity Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
Volga IniguezInstituto de Biologia Molecular y Biotecnologia, Universidad Mayor de San Andres, La Paz, Bolivia.
John McCrackenCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Christophe Luhata LungayoProgramme élargi de vaccination, Ministère de la Santé, Kinshasa, Democratic Republic of the Congo.
Fausta MichaelMinistry of Health, Dar es Salaam, Tanzania.
Gayane SahakyanNational Institute of Health, Ministry of Health, the Republic of Armenia, Yerevan, Armenia.
Gloria Rey-BenitoPan American Health Organization (PAHO), Washington DC, District of Columbia, USA.
Goitom WeldegebrielWHO/AFRO Inter Country Support Team, South and East Africa, Harare, Zimbabwe.
Jason M MwendaWorld Health Organization Regional Office for Africa (WHO/AFRO), Brazzaville, Republic of Congo.
Umesh D ParasharViral Gastroenteritis Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.
Jacqueline E TateViral Gastroenteritis Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.
Multi‐national Subpopulations Study to Evaluate Rotavirus Vaccines (MNSSTER‐V) Project Working Group

Funding

Intramural CDC HHS CC999999NoneWellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

objectivesRotavirus vaccine clinical trials and post-licensure evaluations found malnourished children may have lower protection against rotavirus diarrhea hospitalizations than well-nourished children. On a population level, rotavirus vaccines are less protective in high child mortality settings.

methodsWe analyzed rotavirus vaccine effectiveness (VE) among malnourished and well-nourished children categorized using four anthropometric malnutrition indicators, birthweight, and reported malnutrition from medium to high child mortality countries in the Multi-National Subpopulations Study to Evaluate Rotavirus Vaccines (MNSSTER-V) dataset. We calculated child-level z-scores for weight-for-age, length-for-age, weight-for-length, and mid-upper arm circumference (MUAC), and the site-level proportion implausible z-scores. Sites with published VE estimates by nutritional status or those with <3% implausible values were included in the final analysis. Z-scores <-2 were considered moderate-to-severe malnutrition and <-3 were considered severe malnutrition. We calculated complete series rotavirus VE in each malnourished and well-nourished group using an unconditional adjusted logistic regression model, where VE = (1 - odds ratio of vaccination among cases and controls) × 100, where cases and controls were children who tested rotavirus positive and negative, respectively.

resultsComplete series VE was more protective among children without stunting (normal length-for-age) (59%; 95% confidence interval [CI]: 49-67) compared to children with moderate-to-severe stunting (42%; 95% CI: 19-58) and severe stunting (31%; 95%CI: -14 to 58). Adjusted VE point estimates were similar among malnourished and well-nourished children using the other anthropometric and birthweight indicators.

conclusionsOur findings clearly show that chronic malnutrition negatively impacted rotavirus VE. Efforts to address and prevent malnutrition generally may further reduce the burden of rotavirus morbidity and mortality.

Indexed as

Child Nutrition DisordersMalnutritionRotavirus InfectionsRotavirus VaccinesVaccine EfficacyAdministration, OralChild, PreschoolDiarrheaFemaleHumansInfantMaleNutritional StatusRotavirus Vaccinesdiarrheaimmunizationmalnutritionstuntingvaccination

Identifiers

PMID41486460
PMCPMC12794440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.